Core Viewpoint - JBB BUILDERS plans to acquire 100% equity of Chengdu Jianfu Convenience Store Management Co., Ltd. for a total consideration of RMB 120 million, aiming to diversify its revenue sources and enter the convenience store business [1] Group 1: Acquisition Details - The acquisition is set to take place on January 29, 2026, and involves the purchase from Xiamen Jianfu Chain Management Co., Ltd. [1] - The target company operates convenience stores in Sichuan Province, China, and has a robust network of upstream suppliers and downstream customers [1] - The target company has 65 directly operated stores and 30 franchised stores, indicating a significant operational presence [1] Group 2: Strategic Rationale - The company views this acquisition as a mature and suitable investment opportunity to venture into the convenience store sector [1] - By leveraging its existing network, store locations, and supply chain resources, the company aims to facilitate its entry into the new convenience store business [1] - The acquisition is expected to provide comprehensive and ongoing support, contributing to the diversification of the group's revenue sources post-completion [1]

董秘回答(新宙邦SZ300037)： 投资者提问： 新宙邦公司，您好！2026年是公司30周岁，祝福公司 同行三十载 · 同心启未来｜新宙邦成立30周年 Logo正式发布！其中形象设计强调了公司深耕电子化学品领域的专业属性，更传递出企业拓展多元化 业务、加速全球化布局的蓬勃活力。 可公司董秘却在回答投资者提问时强调：公司从未涉及多元化， 始终聚焦于电子化学品和功能材料。建议公司管理层学习同行优秀的上市公司如何打造公司形象，董秘 处的工作效率堪忧。谢谢！ 您好，感谢您的关注和建议。公司的使命是通过电子化学品及功能材料创造美好未来，愿景是成为电子 化学品及功能材料领域的全球领导者。公司的多元化业务是在聚焦电子化学品及功能材料这个大主体下 的业务多元化，并不会超出这个范畴去发展其他多元化。目前公司核心三大业务板块包含电池化学品、 有机氟化学品和电子信息化学品，均严格根植于电子化学品及功能材料这一主航道，这既是我们的专业 属性，也是持续创新的基础。未来，我们会以更积极、更透明的态度做好资本市场沟通工作，再次感谢 您的建议。查看更多董秘问答>> 免责声明：本信息由新浪财经从公开信息中摘录，不构成任何投资建议；新浪财经不 ...

Core Viewpoint - Tianshui Zhongxing Mushroom Industry Co., Ltd. (referred to as "Zhongxing Mushroom") expects significant profit growth for the fiscal year 2025, driven by rising product prices and increased production capacity [1][2] Financial Performance - The company anticipates a net profit attributable to shareholders of 300 million to 350 million yuan, representing a year-on-year increase of 134.32% to 173.37% [1] - The expected net profit after deducting non-recurring gains and losses is projected to be between 269 million and 319 million yuan, reflecting a year-on-year growth of 192.57% to 247.06% [1] - Financial expenses are expected to decrease by approximately 20 million yuan due to changes in market interest rates, exchange rates, and interest capitalization [1] Business Strategy and Development - Zhongxing Mushroom focuses on the research, cultivation, and sales of edible and medicinal fungi, with leading production capacities for enoki mushrooms and button mushrooms [1] - The company has established production bases in multiple provinces, including Gansu, Shaanxi, Shandong, Jiangsu, Henan, Sichuan, Anhui, and Hubei [1] - In 2025, the company plans to diversify its business by advancing the industrialization of Cordyceps sinensis and other rare edible and medicinal fungi [1][2] Investment Projects - In June 2025, Zhongxing Mushroom signed investment agreements to establish Sichuan Zhongxing Mushroom Technology Co., Ltd. with an investment of 700 million yuan for a "Southwest Headquarters Base Project" focused on the industrialization of Cordyceps sinensis [2] - The wholly-owned subsidiary, Tianshui Zhong'an Biotechnology Co., Ltd., will also shift its production focus to the industrialization of Cordyceps sinensis [2] - Another subsidiary, Meishan Changhong Agricultural Biotechnology Co., Ltd., will implement technological upgrades starting May 2024 to explore the research and cultivation of rare edible and medicinal fungi [2]

Core Viewpoint - The company has entered into a strategic cooperation memorandum with Mingzhi Medical Technology (Shanghai) Co., Ltd. to integrate core resources using artificial intelligence technology, focusing on real-world research in oncology and innovation in traditional Chinese medicine [1][2] Group 1: Strategic Cooperation - The memorandum aims to promote deep integration and industrial upgrading of "medical + technology + scenarios" [1] - The collaboration will leverage Mingzhi Medical's technological and resource advantages to support the company's transition from traditional property and asset management to a digital AI healthcare service enterprise [1] - Specific cooperation directions include building a digital marketing management system for pharmaceutical companies and a collaborative platform for digital clinical trials [1] Group 2: Business Diversification - The company operates two reportable segments: property management and property development and investment, with operations in China, the United States, and the United Kingdom [2] - The strategic cooperation is expected to enhance the company's financial performance and profitability, aligning with the overall interests of the company and its shareholders [2] - The company is actively seeking business diversification to broaden its revenue sources and improve shareholder returns [2]

Core Viewpoint - Le Shi International Holdings (01529) has announced a construction agreement for the Jiangxi Le Lao Hao Traditional Chinese Medicine Logistics Industrial Park project, aimed at enhancing the quality of storage services for traditional Chinese medicine products [1] Group 1: Project Details - The construction contract was signed on January 23, 2026, between Jiangxi Le Lao Hao Traditional Chinese Medicine Industry Technology Development Co., Ltd. (the owner) and Fuzhou Chuanghong Construction Engineering Co., Ltd. (the contractor) [1] - The project will be located in the Dongxiang District of Fuzhou City, Jiangxi Province, China, specifically south of Chuangye Avenue and west of Anshi Mingzhu [1] Group 2: Strategic Importance - The logistics industrial park will not only serve the storage and distribution of traditional Chinese medicine but will also support other business segments of the group, including healthcare and wellness [1] - The board believes that this strategic initiative will diversify the company's operations, support long-term development, and enhance shareholder profitability and returns [1]

Core Viewpoint - Le Shi International Holdings (01529.HK) has announced a construction contract for a Traditional Chinese Medicine logistics industrial park in Jiangxi Province, aiming to enhance the quality of storage services for TCM products and support long-term growth and shareholder returns [1]. Group 1 - The company has entered into a construction agreement with Fuzhou Chuanghong Construction Engineering Co., Ltd. for the development of the Jiangxi Le Lao Hao TCM Logistics Industrial Park [1]. - The project will be located in the Dongxiang District of Fuzhou City, Jiangxi Province, specifically south of Chuangye Avenue and west of Anshi Mingzhu [1]. - The logistics industrial park will serve various business segments of the group, including TCM storage, distribution, healthcare, and wellness, thereby expanding market opportunities [1]. Group 2 - The board believes that this strategic initiative will support the diversification of the group's business and enhance long-term development [1]. - The project is expected to improve shareholder profitability and returns through the enhancement of service quality in TCM product logistics [1].

Core Viewpoint - Le Shi International Holdings (01529) has announced a construction agreement for the Jiangxi Le Lao Hao Traditional Chinese Medicine Logistics Industrial Park project, aimed at enhancing the quality of storage services for traditional Chinese medicine products [1] Group 1: Project Details - The construction contract was signed on January 23, 2026, between Jiangxi Le Lao Hao Traditional Chinese Medicine Industry Technology Development Co., Ltd. (the owner) and Fuzhou Chuanghong Construction Engineering Co., Ltd. (the contractor) [1] - The project will be located in the Dongxiang District of Fuzhou City, Jiangxi Province, China, specifically south of Chuangye Avenue and west of Anshi Mingzhu [1] Group 2: Strategic Importance - The logistics industrial park will not only serve the storage and distribution of traditional Chinese medicine but will also support other business segments of the group, including healthcare and wellness [1] - The board believes that this strategic initiative will diversify the company's operations, support long-term development, and enhance shareholder profitability and returns [1]

Core Viewpoint - The company, Junyu Foundation (01757), is expanding its business operations into the financial services sector, aiming to diversify its revenue sources and enhance shareholder value [1] Group 1: Company Overview - Junyu Foundation is primarily engaged in providing foundation engineering services in Hong Kong, including excavation, lateral support works, cap construction and demolition, underground drainage, earthworks, and structural reinforcement services [1] - The company also rents machinery to third-party construction firms [1] Group 2: New Business Development - The company intends to develop new business activities in the financial services sector, focusing on regulated activities under Class 1 (securities trading), Class 4 (advising on securities), Class 9 (asset management), and trust services [1] - The board believes that the strong macro support from government policies will bolster the prospects of the financial services industry in Hong Kong [1] Group 3: Strategic Expansion - The board views the initiation of this new business as a strategic expansion of the company's operations, aimed at diversifying income sources and seizing new market opportunities within the financial services sector [1] - This development is expected to align with the overall interests of the company and its shareholders [1]

Core Viewpoint - The company, Junyu Foundation (01757.HK), is expanding its business into the financial services sector, aiming to diversify its revenue sources and enhance shareholder value [1] Group 1: Company Overview - Junyu Foundation is primarily engaged in providing foundation engineering services in Hong Kong, including excavation, lateral support works, cap construction and demolition, underground drainage, earthworks, and structural reinforcement services [1] - The company also rents machinery to third-party construction firms [1] Group 2: New Business Development - The company intends to develop new business activities in the financial services sector, focusing on regulated activities under Class 1 (securities trading), Class 4 (advising on securities), Class 9 (asset management), and trust services [1] - The board believes that the macro support from government policies indicates a strong outlook for the financial services industry in Hong Kong [1] - This strategic expansion into financial services is seen as a way to diversify income sources and seize new market opportunities within the financial sector [1]

Group 1 - The core viewpoint of the article is that Junyu Foundation (01757) is expanding its business operations into the financial services sector, aiming to diversify its revenue sources and enhance shareholder value [1] Group 2 - The company primarily operates as a subcontractor in Hong Kong, providing foundation engineering services, including excavation, lateral support works, demolition, underground drainage, earthworks, and structural reinforcement services [1] - In addition to its core services, the company also rents machinery to third-party construction firms [1] - The board of directors is actively seeking to improve the company's operational and financial status by introducing new business lines [1] Group 3 - The new business will focus on regulated activities under Class 1 (securities trading), Class 4 (advising on securities), Class 9 (asset management), and trust services [1] - The board believes that the macro support from government policies indicates a strong outlook for the financial services industry in Hong Kong [1] - The expansion into financial services is seen as a strategic move to diversify income sources and seize new market opportunities within the financial sector [1]